Cargando…

Myositis autoantibodies in a racially diverse population of children with idiopathic inflammatory myopathies

BACKGROUND: Juvenile idiopathic inflammatory myopathies (JIIMs) is a group of autoimmune disorders, including juvenile dermatomyositis (JDM), juvenile polymyositis (JPM) and overlap myositis, that are characterized by proximal muscle weakness, elevated levels of serum muscle enzymes, and pathognomon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perron, Megan Mariko, Vasquez-Canizares, Natalia, Tarshish, Gabriel, Wahezi, Dawn M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199392/ https://www.ncbi.nlm.nih.gov/pubmed/34118936 http://dx.doi.org/10.1186/s12969-021-00574-6

Ejemplares similares

Impact of SARS-CoV-2 on the clinical presentation of juvenile idiopathic inflammatory myopathies
por: Perfetto, Jessica, et al.
Publicado: (2023)

The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies
por: Rider, Lisa G., et al.
Publicado: (2013)

Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria
por: To, Fergus, et al.
Publicado: (2019)

Clinical Usefulness of Autoantibodies in Idiopathic Inflammatory Myositis
por: García-De La Torre, Ignacio
Publicado: (2015)

Disease Specific Autoantibodies in Idiopathic Inflammatory Myopathies
por: Stuhlmüller, Bruno, et al.
Publicado: (2019)

Narrative review of autoantibodies in idiopathic inflammatory myopathies
por: Liu, Yilin, et al.
Publicado: (2021)

Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study
por: Yang, Hanbo, et al.
Publicado: (2017)

Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients
por: Betteridge, Z., et al.
Publicado: (2019)

Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features
por: Yasin, S. A., et al.
Publicado: (2019)

Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies
por: Ghirardello, Anna, et al.
Publicado: (2023)

The impact of the COVID-19 pandemic on patients with juvenile idiopathic inflammatory myopathies
por: Wahezi, Dawn M., et al.
Publicado: (2023)

Comparison of Muscle Biopsy Features with Myositis Autoantibodies in Inflammatory Myopathies: A Pilot Experience
por: Gudipati, Archana, et al.
Publicado: (2023)

Correction to: identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study
por: Yang, Hanbo, et al.
Publicado: (2018)

Decreased Serum 25-(OH)-D Level Associated With Muscle Enzyme and Myositis Specific Autoantibodies in Patients With Idiopathic Inflammatory Myopathy
por: Yu, Zhen, et al.
Publicado: (2021)

Coexistence of Multiple Myositis-Specific Antibodies in Patients with Idiopathic Inflammatory Myopathies
por: Huang, Hung-Ling, et al.
Publicado: (2022)

Association between self-reported race and ethnicity and myositis-specific autoantibodies in a diverse cohort of patients with inflammatory myopathy
por: Beam, Michael J., et al.
Publicado: (2023)

The Role of Myositis-Specific and Myositis-Associated Autoantibodies and the Activation of Type I Interferon Pathway in the Generation of Clinical Phenotypes of Inflammatory Myopathies
por: Skarlis, Charalampos, et al.
Publicado: (2023)

Type 1 interferon signature in peripheral blood mononuclear cells and monocytes of idiopathic inflammatory myopathy patients with different myositis-specific autoantibodies
por: Li, Mengdi, et al.
Publicado: (2023)

Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies
por: Yoshifuji, Hajime
Publicado: (2016)

Role of Myokines in Myositis Pathogenesis and Their Potential to be New Therapeutic Targets in Idiopathic Inflammatory Myopathies
por: Mageriu, Vlad, et al.
Publicado: (2020)

Autoimmune Idiopathic Inflammatory Myopathies: Pharmacological Differences and Similarities by Type of Myositis and by Sociodemographic Variables
por: Valladales-Restrepo, Luis Fernando, et al.
Publicado: (2022)

Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies
por: Leclair, Valérie, et al.
Publicado: (2023)

Anti–Valosin‐Containing Protein (VCP/p97) Autoantibodies in Inclusion Body Myositis and Other Inflammatory Myopathies
por: Amlani, Adam, et al.
Publicado: (2022)

Profile of specific and associated autoantibodies in patients with idiopathic inflammatory myopathies in a Colombian population
por: Hormaza-Jaramillo, Andrés, et al.
Publicado: (2022)

Significance of Myositis Autoantibody in Patients with Idiopathic Interstitial Lung Disease
por: Song, Ju Sun, et al.
Publicado: (2015)

Acute Hemorrhagic Myositis in Inflammatory Myopathy and Review of the Literature
por: Van Gelder, Howard, et al.
Publicado: (2014)

Fever, Myositis, and Paralysis: Is This Inflammatory Myopathy or Neuroinvasive Disease?
por: Kiran, Aneeta R., et al.
Publicado: (2016)

Investigating Idiopathic Inflammatory Myopathy; Initial Cross Speciality Experience with Use of the Extended Myositis Antibody Panel
por: O'Connor, Antoinette, et al.
Publicado: (2017)

A novel autoantibody targeting calreticulin is associated with cancer in patients with idiopathic inflammatory myopathies
por: Chen, He, et al.
Publicado: (2020)

Prevalence of myositis specific and associated antibodies in a cohort of patients affected by idiopathic NSIP and no hint of inflammatory myopathies
por: Conticini, Edoardo, et al.
Publicado: (2023)

3233 Von Willebrand Factor is Localized in the Extravascular tissue of Patients with Juvenile Scleroderma
por: Canizares, Natalia Vasquez, et al.
Publicado: (2019)

Effect of Adalimumab on Refractory Arthritis in Juvenile Idiopathic Inflammatory Myopathy with Anti-MDA5 Autoantibody
por: Miyamae, Takako, et al.
Publicado: (2018)

Myositis autoantibodies and clinical phenotypes
por: Ghirardello, Anna, et al.
Publicado: (2014)

Analysis of myositis autoantibodies in Chinese patients with cancer‐associated myositis
por: Li, Liubing, et al.
Publicado: (2020)

Resistin in idiopathic inflammatory myopathies
por: Filková, Mária, et al.
Publicado: (2012)

Malignancy and Idiopathic Inflammatory Myopathies
por: Ungprasert, Patompong, et al.
Publicado: (2013)

Idiopathic inflammatory myopathies and the lung
por: Lega, Jean-Christophe, et al.
Publicado: (2015)

Autoantibodies in the pathogenesis of idiopathic inflammatory myopathies: Does the endoplasmic reticulum stress response have a role?
por: Corona-Sanchez, Esther Guadalupe, et al.
Publicado: (2022)

Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies
por: Choi, May Y., et al.
Publicado: (2023)

Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease
por: Mammen, Andrew L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hml5lv5gg7ie408ne735n1f1pm